Frontlight ResearchEarly access
CompletedNo phase
Identification of New Inborn Errors of Immunity
Key facts
- Who runs it
- University of Zurich
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 9 people enrolled
- Started
- 23 Sept 2016
- Ended
- 31 Aug 2025
- Type of study
- Observational
- Treatments tested
- Diagnostic Test
- Record updated
- 6 May 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Patients with primary immunodeficiency (PID)
- Male and Female participants 0 years to adult age (any)
- Written informed consent by the participant after information about the research project
Who cannot take part
- Secondary immunodeficiency
- Refusal to enter the study
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Analysis of DNA samples of patients with molecularly undetermined PID by whole exome/genome sequencing.
Read full original descriptionShow less
Transcriptome analysis of patients with molecularly undetermined PID.
The group in the trial
- Patients with PID
Treatment: Diagnostic Test
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Towards Identification of New Inborn Errors of Immunity by Whole Exome/Genome Sequencing
- Record updated
- 6 May 2026